The selective role of myosin VI in lymphoid leukemia cell migration

Leuk Res. 2010 Dec;34(12):1656-62. doi: 10.1016/j.leukres.2010.04.018. Epub 2010 May 20.

Abstract

Several myosin isotypes are discussed to be involved in the migration of various cells ranging from tumor cells to leukocytes. We investigated the involvement of myosins II and VI in the lymphoid leukemia cells lines Jurkat, NB4, Dohh-2, and Molt-4 by a three-dimensional, collagen-based migration assay. Down-regulation of myosin VI by siRNA significantly reduced the migratory activity of all cells, whereas the pharmacological inhibition of non-muscle myosin II using blebbistatin had only marginal influence. Therefore, in contrast to differentiated leukocytes and cells from solid tumors, myosin VI plays a crucial role in the migration of leukemic cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Movement*
  • Heterocyclic Compounds, 4 or More Rings / pharmacology
  • Humans
  • Jurkat Cells
  • K562 Cells
  • Leukemia, Lymphoid / genetics
  • Leukemia, Lymphoid / metabolism*
  • Leukemia, Lymphoid / pathology
  • Myosin Heavy Chains / genetics
  • Myosin Heavy Chains / metabolism*
  • Myosin Type II / antagonists & inhibitors
  • Myosin Type II / genetics
  • Myosin Type II / metabolism
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • RNA, Small Interfering / genetics

Substances

  • Heterocyclic Compounds, 4 or More Rings
  • Neoplasm Proteins
  • RNA, Small Interfering
  • myosin VI
  • blebbistatin
  • Myosin Type II
  • Myosin Heavy Chains